Carl Zeiss Meditec AG (FRA:AFXA)

Market Cap	3.79B
Revenue (ttm)	2.18B
Net Income (ttm)	150.13M
Shares Out	n/a
EPS (ttm)	1.71
PE Ratio	25.26
Forward PE	21.88
Dividend	0.38 (0.87%)
Ex-Dividend Date	Mar 28, 2025

Volume	n/a
Average Volume	18
Open	43.40
Previous Close	44.80
Day's Range	43.40 - 43.40
52-Week Range	39.60 - 70.00
Beta	n/a
RSI	49.85
Earnings Date	Dec 11, 2025

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1846
• Employees: 5,730
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AFXA

Financial Performance

In 2024, Carl Zeiss Meditec AG's revenue was 2.07 billion, a decrease of -1.11% compared to the previous year's 2.09 billion. Earnings were 178.73 million, a decrease of -38.45%.